SRSF2 and cancer: The C > T mutation of rs3200401 may alter the structural features of MALAT1 and result in loss of MALAT1-SRSF2 binding, downregulation of SRSF2 phosphorylation, changes in the alternative splicing of pre-mRNAs, and finally changes in expression levels of cancer-associated genes [26].